Research Supplement to Promote Diversity: Carlos Torres (R03EB031495 Parent Award)
Research Supplement to Promote Diversity: Carlos Torres (R03EB031495 Parent Award)
批准号:
10592146
负责人:
Kevin James McHugh
金额:
$1.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2022-12-31
关键词:
AffectAntigensApplications GrantsAwardChildCommunicable DiseasesDevelopmentDoseDrug Delivery SystemsElectrospinningEncapsulatedEnrollmentEquipmentExhibitsFormulationGoalsHispanicIn VitroInjectionsInvestigationKineticsLabelMethodsModelingMorphologyNeedlesParentsPatientsPhysiologic pulsePolymersPopulationProcessProductionProteinsRegimenReporterReproducibilityResearchResource-limited settingResourcesRiskRural CommunityScienceStructureTechniquesTimeUninsuredVaccinationVaccinesWorkWorld Health Organizationaqueousbasecommunity collegecontrolled releasefight againsthealth care availabilityimprovedin vivolow and middle-income countriesmacromoleculemalenegative affectparent grantparticlepreventable deathtoolundergraduate studentvaccination schedule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Every year an estimated 19.4 million children do not receive the set of vaccines recommended by the World
Health Organization, leading to 1.5 million vaccine-preventable deaths.1,2 A majority of undervaccinated children
live in low- and middle-income countries and often have limited access to healthcare.2,3 Nearly 6 million of these
children receive at least one vaccine dose, but remain at risk because they have not completed the full dosing
regimen.4,5 A vaccination method that delivers all doses of a vaccine, or multiple vaccines, in a single injection
would enable children with even one-time access to healthcare to be fully protected from the corresponding
infectious disease. Unfortunately, most controlled-release drug delivery systems exhibit continuous release
kinetics, which is vastly different from traditional soluble vaccines administered in multiple discrete doses over a
course of months. One recent study has described the development of biodegradable microparticle platform with
a polymer shell encapsulating a vaccine-loaded core that exhibits delayed, pulsatile release after a period
determined by the polymer degradation rate.6 By injecting patients with a mixed population of particles with
different degradation rates, vaccine can be released as discrete pulses, thereby mimicking traditional vaccination
schedules known to be safe and effective. Unfortunately, the original microparticle production method negatively
affects antigen stability, requires the use of large-gauge needles, and is low-throughput. This project seeks to
overcome these challenges by preparing microparticles using coaxial electrospraying, a single-step fabrication
process that can produce a single aqueous, vaccine-loaded core surrounded by a shell of polymer. The parent
proposal first aims to create small core-shell microparticles with dense polymeric shells that demonstrate the
delayed, pulsatile release of macromolecules in vitro and in vivo using fluorescently-labeled model molecules
and reporter proteins to assess protein stability within the microparticles. This diversity supplement will expand
the scope of work previously proposed to support the work of Carlos Torres, a Hispanic male undergraduate
student at Houston Community College, including the investigation of coaxial electrospraying parameters
between pieces of electrospraying equipment. The goal of Carlos’s work is to identify the key features that affect
core-shell microparticle morphology and release kinetics and develop solutions that allows electrospraying
conditions to be readily transferred between different pieces of equipment. If successful, Carlos’s work will
enhance the reproducibility of science and allow different research groups to work in unison to improve
electrosprayed particle formulations for single-injection vaccination as well as other drug delivery applications.
Ultimately, these particles could serve as a key tool in the fight against infectious disease both in the developing
world where resources are limited and in the developed world, where uninsured children and rural communities
show consistently lower vaccination coverage.7
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1126/scitranslmed.abm1732
发表时间:
2022-10-12
期刊:
Science translational medicine
影响因子:
17.1
作者:
[]
通讯作者:
DOI:
10.3390/bioengineering8110155
发表时间:
2021-10-24
期刊:
Bioengineering (Basel, Switzerland)
影响因子:
--
作者:
[Pogostin BH, McHugh KJ]
通讯作者:
McHugh KJ
Research Supplement to Promote Diversity: Belvi Bwela (R03EB031495 Parent Award)
-
批准号:10592142
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Kevin James McHugh
-
依托单位:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
-
批准号:10195135
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Solvent Evaporator Equipment Supplement to R35GM143101
-
批准号:10799251
-
项目类别:
-
资助金额:$5.93万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
-
批准号:10277139
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
-
批准号:10372138
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
-
批准号:10890222
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Research Supplement to Promote Diversity: Mei-Li Laracuente (1R35GM143101 Parent Award)
-
批准号:10631614
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
-
批准号:10488240
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
-
批准号:10667652
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2021
-
负责人:Kevin James McHugh
-
依托单位:
Biomaterial Strategies for Modulating the Immune Response
-
批准号:10232052
-
项目类别:
-
资助金额:$10.67万
-
财政年份:2020
-
负责人:Kevin James McHugh
-
依托单位:
Fluorescence-based molecular imaging of in vivo release kinetics
-
批准号:9429542
-
项目类别:
-
资助金额:$6.12万
-
财政年份:2017
-
负责人:Kevin James McHugh
-
依托单位:
Fluorescence-based molecular imaging of in vivo release kinetics
-
批准号:9257616
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2017
-
负责人:Kevin James McHugh
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: